Isolated chronic idiopathic neutropenia (CIN) is a rare disease with multiple contributing etiologies that must be ruled out before establishing a diagnosis. We studied clinical and molecular data of 238 consecutive adult patients with CIN. Autoimmune neutropenia was present in 28% of our cohort. In contrast, T cell-mediated neutropenia was the main underlying pathological mechanism among patients with T cell expansions, such as T-cell large granular lymphocytic leukemia (T-LGL) and T cell clonopathy of undetermined signifcance, found in 37% and 8% of cases, respectively. Patients with neutropenia also had hypogammaglobulinemia (6%) and/or monoclonal gammopathy of undetermined signifcance (5%). NGS application has further broadened the spectrum of causes of CIN by including manifestations of clonal hematopoiesis, present in 12% of cases. TET2 (3%), TP53 (2%), and IDH1/IDH2 (2%) mutations were the most commonly found and were enriched in cases with T-LGL. We show that these clinico-molecular associations can be simultaneously present, complicating a proper diagnostic distinction within the broader entity of seemingly idiopathic neutropenia of autoimmune origin. Identifcation of etiologic culprits may also guide rational selection of therapies.

Ogbue, O.d., Kewan, T., Bahaj, W.s., Gurnari, C., Visconte, V., Maciejewski, J.p. (2023). New approaches to idiopathic neutropenia in the era of clonal hematopoiesis. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 12(1) [10.1186/s40164-023-00403-4].

New approaches to idiopathic neutropenia in the era of clonal hematopoiesis

Gurnari C.
Formal Analysis
;
2023-01-01

Abstract

Isolated chronic idiopathic neutropenia (CIN) is a rare disease with multiple contributing etiologies that must be ruled out before establishing a diagnosis. We studied clinical and molecular data of 238 consecutive adult patients with CIN. Autoimmune neutropenia was present in 28% of our cohort. In contrast, T cell-mediated neutropenia was the main underlying pathological mechanism among patients with T cell expansions, such as T-cell large granular lymphocytic leukemia (T-LGL) and T cell clonopathy of undetermined signifcance, found in 37% and 8% of cases, respectively. Patients with neutropenia also had hypogammaglobulinemia (6%) and/or monoclonal gammopathy of undetermined signifcance (5%). NGS application has further broadened the spectrum of causes of CIN by including manifestations of clonal hematopoiesis, present in 12% of cases. TET2 (3%), TP53 (2%), and IDH1/IDH2 (2%) mutations were the most commonly found and were enriched in cases with T-LGL. We show that these clinico-molecular associations can be simultaneously present, complicating a proper diagnostic distinction within the broader entity of seemingly idiopathic neutropenia of autoimmune origin. Identifcation of etiologic culprits may also guide rational selection of therapies.
2023
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MEDS-09/B - Malattie del sangue
English
Ogbue, O.d., Kewan, T., Bahaj, W.s., Gurnari, C., Visconte, V., Maciejewski, J.p. (2023). New approaches to idiopathic neutropenia in the era of clonal hematopoiesis. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 12(1) [10.1186/s40164-023-00403-4].
Ogbue, Od; Kewan, T; Bahaj, Ws; Gurnari, C; Visconte, V; Maciejewski, Jp
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
New approaches to idiopathic.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.74 MB
Formato Adobe PDF
1.74 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/409761
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact